These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 35163328)

  • 1. Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.
    Mohamed NA; Marei I; Crovella S; Abou-Saleh H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases.
    Hu B; Boakye-Yiadom KO; Yu W; Yuan ZW; Ho W; Xu X; Zhang XQ
    Adv Healthc Mater; 2020 Aug; 9(16):e2000336. PubMed ID: 32597562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.
    Pala R; Anju VT; Dyavaiah M; Busi S; Nauli SM
    Int J Nanomedicine; 2020; 15():3741-3769. PubMed ID: 32547026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bio-inspired nanomaterials as novel options for the treatment of cardiovascular disease.
    Bose RJ; Ha K; McCarthy JR
    Drug Discov Today; 2021 May; 26(5):1200-1211. PubMed ID: 33561512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances on nanoparticle-based therapies for cardiovascular diseases.
    Soumya RS; Raghu KG
    J Cardiol; 2023 Jan; 81(1):10-18. PubMed ID: 35210166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease.
    Ullah A; Ullah M; Lim SI
    Curr Probl Cardiol; 2024 Apr; 49(4):102396. PubMed ID: 38266693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine and drug delivery.
    Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
    Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology translation in vascular diseases: From design to the bench.
    Zhou Y; Yue T; Ding Y; Tan H; Weng J; Luo S; Zheng X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1919. PubMed ID: 37548140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle: A Promising Player in Nanomedicine and its Theranostic Applications for the Treatment of Cardiovascular Diseases.
    Saeed S; Ud Din SR; Khan SU; Gul R; Kiani FA; Wahab A; Zhong M
    Curr Probl Cardiol; 2023 May; 48(5):101599. PubMed ID: 36681209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine for Atherosclerosis: Molecular Imaging and Treatment.
    Karagkiozaki V; Logothetidis S; Pappa AM
    J Biomed Nanotechnol; 2015 Feb; 11(2):191-210. PubMed ID: 26349296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure.
    Khan AU; Khan M; Cho MH; Khan MM
    Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases.
    Arshad I; Kanwal A; Zafar I; Unar A; Mouada H; Razia IT; Arif S; Ahsan M; Kamal MA; Rashid S; Khan KA; Sharma R
    Environ Res; 2024 Feb; 242():117795. PubMed ID: 38043894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
    Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
    Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering.
    Shariati L; Esmaeili Y; Rahimmanesh I; Babolmorad S; Ziaei G; Hasan A; Boshtam M; Makvandi P
    Environ Res; 2023 Dec; 238(Pt 1):116933. PubMed ID: 37652218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.
    Kim KS; Song CG; Kang PM
    Antioxid Redox Signal; 2019 Feb; 30(5):733-746. PubMed ID: 29228781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
    Kaur M; Nagpal M; Aggarwal G
    Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
    Gautam RK; Mittal P; Goyal R; Dua K; Mishra DK; Sharma S; Singla RK
    Curr Med Chem; 2024; 31(28):4479-4494. PubMed ID: 37828674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-Systems for Advanced Therapeutics and Diagnosis of Atherosclerosis.
    Gaurav C; Saurav B; Goutam R; Goyal AK
    Curr Pharm Des; 2015; 21(30):4498-508. PubMed ID: 26377651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology-based drug delivery systems for treatment of oral cancer: a review.
    Calixto G; Bernegossi J; Fonseca-Santos B; Chorilli M
    Int J Nanomedicine; 2014; 9():3719-35. PubMed ID: 25143724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.